Sarepta Therapeutics Announces First Quarter 2016 Financial Results and Recent Corporate Developments

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/17/2026

1. NFLX
2. ISRG
3. USB
4. SPY
5. NVDA
6. CFG
7. STT
8. AAPL
9. SLND
10. PEO

Go back to Sarepta Therapeutics Announces First Quarter 2016 Financial Results and Recent Corporate Developments

Sarepta Therapeutics (SRPT) Posts Slightly Smaller Q1 Loss

May 5, 2016 7:04 AM EDT

Sarepta Therapeutics (NASDAQ: SRPT) reported Q1 EPS of ($1.15), $0.13 better than the analyst estimate of ($1.28).

The Company had $140.6 million in cash, cash equivalents, short-term investments and restricted cash as of March 31, 2016 compared to $204.0 million as of December 31, 2015, a decrease of $63.4... More